Latest News and Press Releases

CAMBRIDGE, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company developing human-compatible (HuCo™) organs for the treatment of organ failure, will present new data and host a...

- Proof of concept study resulted in life-supporting organ function and recipient survival of over two years    - Donor kidneys carrying human transgenes resulted in longer survival time CAMBRIDGE,...

CAMBRIDGE, Mass., June 13, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company developing human-compatible organs for the treatment of organ failure, today announced the publication of a...

CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company developing human-compatible organs for the treatment of organ failure, will present new data during the American...

CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company developing human-compatible organs and cells for the treatment of organ failure, today announced that Knut Niss,...

-Agreement leverages Eledon’s investigational anti-CD40L antibody, tegoprubart, as part of eGenesis’ immunosuppression regimen that prevents xenotransplant rejection in nonhuman primate recipients- ...

Dr. Curtis succeeds Paul Sekhri, who remains on Board of Directors Reflects company’s focus on advancement of portfolio toward clinical development CAMBRIDGE, Mass., April 19, 2022 (GLOBE...

CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of Eliezer...

CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing company developing human-compatible (HuCo™) organs and cells, today announced the initiation of a research collaboration...

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today announced the appointment of...